Global Pneumococcal Polysaccharide Vaccine Market Research Report 2020

Global Pneumococcal Polysaccharide Vaccine Market Research Report 2020

Table of Contents
1 Pneumococcal Polysaccharide Vaccine Market Overview
1.1 Product Overview and Scope of Pneumococcal Polysaccharide Vaccine
1.2 Pneumococcal Polysaccharide Vaccine Segment by Type
1.2.1 Global Pneumococcal Polysaccharide Vaccine Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Single Dose Vial
1.2.3 Pre-Filled Syringe
1.3 Pneumococcal Polysaccharide Vaccine Segment by Application
1.3.1 Pneumococcal Polysaccharide Vaccine Sales Comparison by Application: 2020 VS 2026
1.3.2 Children (2-10 Age)
1.3.3 Adult (10-64 Age)
1.3.4 Geriatric (More Than 65 Age)
1.4 Global Pneumococcal Polysaccharide Vaccine Market Size Estimates and Forecasts
1.4.1 Global Pneumococcal Polysaccharide Vaccine Revenue 2015-2026
1.4.2 Global Pneumococcal Polysaccharide Vaccine Sales 2015-2026
1.4.3 Pneumococcal Polysaccharide Vaccine Market Size by Region: 2020 Versus 2026
2 Global Pneumococcal Polysaccharide Vaccine Market Competition by Manufacturers
2.1 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2015-2020)
2.3 Global Pneumococcal Polysaccharide Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Pneumococcal Polysaccharide Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends
2.5.1 Pneumococcal Polysaccharide Vaccine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Pneumococcal Polysaccharide Vaccine Players (Opinion Leaders)
3 Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario by Region
3.1 Global Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.3.1 North America Pneumococcal Polysaccharide Vaccine Sales by Country
3.3.2 North America Pneumococcal Polysaccharide Vaccine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.4.1 Europe Pneumococcal Polysaccharide Vaccine Sales by Country
3.4.2 Europe Pneumococcal Polysaccharide Vaccine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Region
3.5.2 Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.6.1 Latin America Pneumococcal Polysaccharide Vaccine Sales by Country
3.6.2 Latin America Pneumococcal Polysaccharide Vaccine Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country
3.7.2 Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Pneumococcal Polysaccharide Vaccine Historic Market Analysis by Type
4.1 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2015-2020)
4.2 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2015-2020)
4.3 Global Pneumococcal Polysaccharide Vaccine Price Market Share by Type (2015-2020)
4.4 Global Pneumococcal Polysaccharide Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Pneumococcal Polysaccharide Vaccine Historic Market Analysis by Application
5.1 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2015-2020)
5.2 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2015-2020)
5.3 Global Pneumococcal Polysaccharide Vaccine Price by Application (2015-2020)
6 Company Profiles and Key Figures in Pneumococcal Polysaccharide Vaccine Business
6.1 Merck & Co., Inc.
6.1.1 Corporation Information
6.1.2 Merck & Co., Inc. Description, Business Overview and Total Revenue
6.1.3 Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Merck & Co., Inc. Products Offered
6.1.5 Merck & Co., Inc. Recent Development
6.2 Pfizer Inc.
6.2.1 Pfizer Inc. Pneumococcal Polysaccharide Vaccine Production Sites and Area Served
6.2.2 Pfizer Inc. Description, Business Overview and Total Revenue
6.2.3 Pfizer Inc. Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Pfizer Inc. Products Offered
6.2.5 Pfizer Inc. Recent Development
6.3 Glaxosmithkline Plc.
6.3.1 Glaxosmithkline Plc. Pneumococcal Polysaccharide Vaccine Production Sites and Area Served
6.3.2 Glaxosmithkline Plc. Description, Business Overview and Total Revenue
6.3.3 Glaxosmithkline Plc. Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Glaxosmithkline Plc. Products Offered
6.3.5 Glaxosmithkline Plc. Recent Development
6.4 Sanofi Pasteur
6.4.1 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Production Sites and Area Served
6.4.2 Sanofi Pasteur Description, Business Overview and Total Revenue
6.4.3 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Sanofi Pasteur Products Offered
6.4.5 Sanofi Pasteur Recent Development
6.5 China National Biotec Group
6.5.1 China National Biotec Group Pneumococcal Polysaccharide Vaccine Production Sites and Area Served
6.5.2 China National Biotec Group Description, Business Overview and Total Revenue
6.5.3 China National Biotec Group Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 China National Biotec Group Products Offered
6.5.5 China National Biotec Group Recent Development
6.6 Astellas Pharma Inc
6.6.1 Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Production Sites and Area Served
6.6.2 Astellas Pharma Inc Description, Business Overview and Total Revenue
6.6.3 Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Astellas Pharma Inc Products Offered
6.6.5 Astellas Pharma Inc Recent Development
6.7 Serum Institute of India Pvt. Ltd
6.6.1 Serum Institute of India Pvt. Ltd Pneumococcal Polysaccharide Vaccine Production Sites and Area Served
6.6.2 Serum Institute of India Pvt. Ltd Description, Business Overview and Total Revenue
6.6.3 Serum Institute of India Pvt. Ltd Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Serum Institute of India Pvt. Ltd Products Offered
6.7.5 Serum Institute of India Pvt. Ltd Recent Development
7 Pneumococcal Polysaccharide Vaccine Manufacturing Cost Analysis
7.1 Pneumococcal Polysaccharide Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pneumococcal Polysaccharide Vaccine
7.4 Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pneumococcal Polysaccharide Vaccine Distributors List
8.3 Pneumococcal Polysaccharide Vaccine Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Pneumococcal Polysaccharide Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pneumococcal Polysaccharide Vaccine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Pneumococcal Polysaccharide Vaccine by Type (2021-2026)
10.2 Pneumococcal Polysaccharide Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pneumococcal Polysaccharide Vaccine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Pneumococcal Polysaccharide Vaccine by Application (2021-2026)
10.3 Pneumococcal Polysaccharide Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pneumococcal Polysaccharide Vaccine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Pneumococcal Polysaccharide Vaccine by Region (2021-2026)
10.4 North America Pneumococcal Polysaccharide Vaccine Estimates and Projections (2021-2026)
10.5 Europe Pneumococcal Polysaccharide Vaccine Estimates and Projections (2021-2026)
10.6 Asia Pacific Pneumococcal Polysaccharide Vaccine Estimates and Projections (2021-2026)
10.7 Latin America Pneumococcal Polysaccharide Vaccine Estimates and Projections (2021-2026)
10.8 Middle East and Africa Pneumococcal Polysaccharide Vaccine Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Pneumococcal Polysaccharide Vaccine Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Pneumococcal Polysaccharide Vaccine Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Pneumococcal Polysaccharide Vaccine Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Pneumococcal Polysaccharide Vaccine Manufacturers Covered in This Study
Table 5. Global Pneumococcal Polysaccharide Vaccine Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers (2015-2020)
Table 7. Global Pneumococcal Polysaccharide Vaccine Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Pneumococcal Polysaccharide Vaccine Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Pneumococcal Polysaccharide Vaccine Sales Sites and Area Served
Table 11. Manufacturers Pneumococcal Polysaccharide Vaccine Product Types
Table 12. Global Pneumococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Pneumococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumococcal Polysaccharide Vaccine as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Pneumococcal Polysaccharide Vaccine Players
Table 16. Global Pneumococcal Polysaccharide Vaccine Sales (K Units) by Region (2015-2020)
Table 17. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2015-2020)
Table 18. Global Pneumococcal Polysaccharide Vaccine Revenue (Million US$) by Region (2015-2020)
Table 19. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2015-2020)
Table 20. North America Pneumococcal Polysaccharide Vaccine Sales by Country (2015-2020) (K Units)
Table 21. North America Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2015-2020)
Table 22. North America Pneumococcal Polysaccharide Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2015-2020)
Table 24. Europe Pneumococcal Polysaccharide Vaccine Sales by Country (2015-2020) (K Units)
Table 25. Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2015-2020)
Table 26. Europe Pneumococcal Polysaccharide Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2015-2020)
Table 32. Latin America Pneumococcal Polysaccharide Vaccine Sales by Country (2015-2020) (K Units)
Table 33. Latin America Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2015-2020)
Table 34. Latin America Pneumococcal Polysaccharide Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2015-2020)
Table 40. Global Pneumococcal Polysaccharide Vaccine Sales (K Units) by Type (2015-2020)
Table 41. Global Pneumococcal Polysaccharide Vaccine Sales Share by Type (2015-2020)
Table 42. Global Pneumococcal Polysaccharide Vaccine Revenue (Million US$) by Type (2015-2020)
Table 43. Global Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2015-2020)
Table 44. Global Pneumococcal Polysaccharide Vaccine Price (USD/Unit) by Type (2015-2020)
Table 45. Global Pneumococcal Polysaccharide Vaccine Sales (K Units) by Application (2015-2020)
Table 46. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2015-2020)
Table 47. Global Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Application (2015-2020)
Table 48. Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Corporation Information
Table 49. Merck & Co., Inc. Description and Business Overview
Table 50. Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Merck & Co., Inc. Main Product
Table 52. Merck & Co., Inc. Recent Development
Table 53. Pfizer Inc. Pneumococcal Polysaccharide Vaccine Corporation Information
Table 54. Pfizer Inc. Corporation Information
Table 55. Pfizer Inc. Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Pfizer Inc. Main Product
Table 57. Pfizer Inc. Recent Development
Table 58. Glaxosmithkline Plc. Pneumococcal Polysaccharide Vaccine Corporation Information
Table 59. Glaxosmithkline Plc. Corporation Information
Table 60. Glaxosmithkline Plc. Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Glaxosmithkline Plc. Main Product
Table 62. Glaxosmithkline Plc. Recent Development
Table 63. Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Corporation Information
Table 64. Sanofi Pasteur Corporation Information
Table 65. Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Sanofi Pasteur Main Product
Table 67. Sanofi Pasteur Recent Development
Table 68. China National Biotec Group Pneumococcal Polysaccharide Vaccine Corporation Information
Table 69. China National Biotec Group Corporation Information
Table 70. China National Biotec Group Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. China National Biotec Group Main Product
Table 72. China National Biotec Group Recent Development
Table 73. Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Corporation Information
Table 74. Astellas Pharma Inc Corporation Information
Table 75. Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Astellas Pharma Inc Main Product
Table 77. Astellas Pharma Inc Recent Development
Table 78. Serum Institute of India Pvt. Ltd Pneumococcal Polysaccharide Vaccine Corporation Information
Table 79. Serum Institute of India Pvt. Ltd Corporation Information
Table 80. Serum Institute of India Pvt. Ltd Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Serum Institute of India Pvt. Ltd Main Product
Table 82. Serum Institute of India Pvt. Ltd Recent Development
Table 83. Sales Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Pneumococcal Polysaccharide Vaccine Distributors List
Table 86. Pneumococcal Polysaccharide Vaccine Customers List
Table 87. Market Key Trends
Table 88. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 89. Key Challenges
Table 90. Global Pneumococcal Polysaccharide Vaccine Sales (K Units) Forecast by Type (2021-2026)
Table 91. Global Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 92. Global Pneumococcal Polysaccharide Vaccine Revenue (Million US$) Forecast by Type (2021-2026)
Table 93. Global Pneumococcal Polysaccharide Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 94. Global Pneumococcal Polysaccharide Vaccine Sales (K Units) Forecast by Application (2021-2026)
Table 95. Global Pneumococcal Polysaccharide Vaccine Revenue (Million US$) Forecast by Application (2021-2026)
Table 96. Global Pneumococcal Polysaccharide Vaccine Sales (K Units) Forecast by Region (2021-2026)
Table 97. Global Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 98. Global Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 99. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Pneumococcal Polysaccharide Vaccine
Figure 2. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type: 2020 VS 2026
Figure 3. Single Dose Vial Product Picture
Figure 4. Pre-Filled Syringe Product Picture
Figure 5. Global Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application: 2020 VS 2026
Figure 6. Children (2-10 Age)
Figure 7. Adult (10-64 Age)
Figure 8. Geriatric (More Than 65 Age)
Figure 9. Global Pneumococcal Polysaccharide Vaccine Market Size 2015-2026 (US$ Million)
Figure 10. Global Pneumococcal Polysaccharide Vaccine Sales Capacity (K Units) (2015-2026)
Figure 11. Global Pneumococcal Polysaccharide Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2020
Figure 13. Global Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Pneumococcal Polysaccharide Vaccine Revenue in 2019
Figure 15. Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2015-2020)
Figure 17. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2019
Figure 18. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2015-2020)
Figure 19. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region in 2019
Figure 20. North America Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2019
Figure 21. North America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2019
Figure 22. U.S. Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 23. U.S. Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 25. Canada Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2019
Figure 27. Europe Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2019
Figure 28. Germany Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 29. Germany Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 31. France Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 35. Italy Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 37. Russia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2019
Figure 39. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region in 2019
Figure 40. China Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 41. China Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 43. Japan Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 45. South Korea Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 47. India Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 49. Australia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 53. Indonesia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 55. Thailand Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 57. Malaysia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 59. Philippines Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 61. Vietnam Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2019
Figure 63. Latin America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2019
Figure 64. Mexico Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 65. Mexico Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 67. Brazil Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 69. Argentina Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2019
Figure 72. Turkey Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 73. Turkey Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 75. Saudi Arabia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 77. U.A.E Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Pneumococcal Polysaccharide Vaccine by Type (2015-2020)
Figure 79. Sales Market Share of Pneumococcal Polysaccharide Vaccine by Type in 2019
Figure 80. Revenue Share of Pneumococcal Polysaccharide Vaccine by Type (2015-2020)
Figure 81. Revenue Market Share of Pneumococcal Polysaccharide Vaccine by Type in 2019
Figure 82. Global Pneumococcal Polysaccharide Vaccine Sales Growth by Type (2015-2020) (K Units)
Figure 83. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2015-2020)
Figure 84. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Pneumococcal Polysaccharide Vaccine by Application (2015-2020)
Figure 86. Global Revenue Share of Pneumococcal Polysaccharide Vaccine by Application in 2020
Figure 87. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Glaxosmithkline Plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. China National Biotec Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Astellas Pharma Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Serum Institute of India Pvt. Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Price Trend of Key Raw Materials
Figure 95. Manufacturing Cost Structure of Pneumococcal Polysaccharide Vaccine
Figure 96. Manufacturing Process Analysis of Pneumococcal Polysaccharide Vaccine
Figure 97. Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
Figure 98. Channels of Distribution
Figure 99. Distributors Profiles
Figure 100. Porter's Five Forces Analysis
Figure 101. North America Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 102. North America Pneumococcal Polysaccharide Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 103. Europe Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 104. Europe Pneumococcal Polysaccharide Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 105. Latin America Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 106. Latin America Pneumococcal Polysaccharide Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Asia Pacific Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Bottom-up and Top-down Approaches for This Report
Figure 112. Data Triangulation
Figure 113. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Encephalitis Vaccination Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102

According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......

Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......

Global Avian Influenza Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......

Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......

Global Influenza Vaccine Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......

Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......

2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs